跳至主要内容
临床试验/NL-OMON42883
NL-OMON42883已完成不适用

Magnesium variability study in haemodialysis patients: <br>intra-patient and inter-patient variability of plasma magnesium before and after hemodialysis.<br> - Magnesium variability study

Vrije Universiteit Medisch Centrum0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 64(—)

入选标准

  • - Age *18
  • - Hemodialysis with regular three times weekly dialysis schedule
  • - Hemodialysis since at least 3 months
  • - Standard dialysate Mg2+ 0.5 mmol/L
  • - Providing informed consent

排除标准

  • - Age <18
  • - Intravenous magnesium supplementation that has been started or stopped in the last 2 weeks, or the subject currently receives non-continuous magnesium supplementation. Note: subjects receiving stable continuous intravenous magnesium supplementation including total parenteral nutrition since at least 2 weeks can be included.
  • - Expected cessation of dialysis treatment within 2 weeks after inclusion.

研究者

相似试验